Similarly, SIRT3‐overexpressing AML cells contained a relatively high GSH/GSSG ratio with or without Ara‐C treatment, whereas SIRT3 shRNA decreased GSH/GSSG ratio regardless of cytarabine treatment (Fig 5B). This evidence concerns the gene SIRT3 and acute myeloid leukemia.